CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to BCAB

CAB-AXL-ADC

Phase 2
BioAtla, Inc. (BCAB)

Phase 2

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Undifferentiated Pleomorphic Sarcoma

View Full Landscape
Drug Information

Target Indication

Undifferentiated Pleomorphic Sarcoma

Clinical Trial

NCT03425279

Last updated: 2/15/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.